ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

Cancer Society, Centers Explore Collaboration On Public Issued, Education, Information Activities

January 25, 1991

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002